Zwierzina W D, Kunz F, Miller K
Klin Monbl Augenheilkd. 1985 Dec;187(6):534-6. doi: 10.1055/s-2008-1054394.
Deficiency of Antithrombin III (AT III), which is one of the main inhibitors of blood coagulation, may lead to severe thrombosis and embolism. The authors detected AT III deficiency in two patients with retinal vessel occlusion. Both patients were otherwise healthy. One had recurrent retinal vein thrombosis, the other cilioretinal occlusion. To the authors' knowledge, only one case of retinal vessel occlusion with AT III deficiency has been reported in literature. Furthermore, in the patients reported here retinal vessel occlusion may have been caused by AT III deficiency, which has considerable therapeutic and prophylactic consequences for patients with this disorder. AT III should therefore be determined in retinal vessel occlusion of unknown cause.
抗凝血酶III(AT III)是血液凝固的主要抑制剂之一,其缺乏可能导致严重的血栓形成和栓塞。作者在两名视网膜血管阻塞患者中检测到AT III缺乏。两名患者在其他方面均健康。一名患者有复发性视网膜静脉血栓形成,另一名患者有睫状视网膜阻塞。据作者所知,文献中仅报道过一例伴有AT III缺乏的视网膜血管阻塞病例。此外,在此报道的患者中,视网膜血管阻塞可能由AT III缺乏引起,这对患有该疾病的患者具有相当大的治疗和预防意义。因此,对于病因不明的视网膜血管阻塞,应测定AT III。